Kidney Stones Therapeutic Market Size to grow by USD 537.8 million between 2024-2028
According to a research report “ Kidney Stones Therapeutic Market” by End-user (Hospitals, Specialty clinics, Ambulatory surgical centers) Type (Lithotripsy, Ureteroscopy, Percutaneous nephrolithonomy (PCNL)) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 537.8 million, at a CAGR of 4.96% during the forecast period. In the kidney stones therapeutic market, advancements in urology, particularly in Unified Renal Stone Surgery (URS), have led to the introduction of digital flexible ureteroscopes. These devices offer several advantages over traditional fiber-optic ureteroscopes. Digital flexible ureteroscopes provide enhanced maneuverability and superior visibility, resulting in higher clarity and superior magnification abilities. This enables visualization of the entire collecting system in a greater percentage of cases. Additionally, the mean operating time for digital flexible ureteroscopes is less than that of fiber-optic ureteroscopes, while maintaining similar stone clearance rates. The fiber-optic fibers in traditional ureteroscopes have poor durability and are more prone to breakage during ureteral passage and extreme deflection.
Browse market data tables, figures, and in-depth TOC on “Kidney Stones Therapeutic Market” by End-user (Hospitals, Specialty clinics, Ambulatory surgical centers) Type (Lithotripsy, Ureteroscopy, Percutaneous nephrolithonomy (PCNL)) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By End-user, the Hospitals segment is projected to dominate the market size in 2024
In the healthcare sector, hospitals play a pivotal role in addressing kidney stone diseases through the provision of comprehensive treatment solutions. Multispecialty and government hospitals offer inpatient and outpatient services, utilizing standard and advanced care methods. Hospitals procure kidney stone therapeutics, including medications and urology devices, in bulk, fostering close relationships with suppliers, reimbursement authorities, and government organizations. Their state-of-the-art medical infrastructure caters to diverse patient needs, while strategic partnerships with kidney stone therapeutic manufacturers enable access to advanced solutions and cost-effective procurement.
By Type, Lithotripsy segment is expected to hold the largest market size for the year 2024
In the kidney stones therapeutic market, lithotripsy represents a non-invasive, outpatient treatment for kidney stones up to 20 mm in diameter. This procedure utilizes advanced imaging technologies, such as X-ray or ultrasound, to precisely locate the stone. Subsequently, focused sound waves are employed to non-surgically fragment the kidney stone from outside the body. The absence of instrumentation introduction and the need for only local anesthesia contribute to less patient discomfort compared to ureteroscopy (URS) and percutaneous nephrolithotomy (PCNL). Lithotripsy's non-invasive nature makes it a preferred choice for kidney stone treatment in the market.
North America is forecasted to hold the largest market size by region in 2024
The kidney stones therapeutic market represents a significant business opportunity due to the rising prevalence of kidney stones and the increasing demand for effective treatments. Key players in this market focus on developing innovative solutions, such as minimally invasive procedures and advanced medications, to address the unmet needs of patients. The market is expected to grow steadily due to the increasing awareness and diagnosis rates of kidney stones, as well as the increasing healthcare expenditures in both developed and developing economies.
The Kidney Stones Therapeutic Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
Title: Kidney Stones Therapeutic Market: Advancements in Minimally Invasive Procedures for Struvite and Calcium Oxalate Stones The Kidney Stones Therapeutic Market has witnessed significant growth due to the increasing prevalence of urolithiasis, a condition characterized by the formation of kidney stones. The most common types of kidney stones are Struvite, caused by infection, and Calcium Oxalate, caused by dietary factors such as fast food consumption. Traditional treatments for kidney stones include open surgeries like Percutaneous Renal Lithotomy and Extracorporeal Shock Wave Lithotripsy (ESWL). However, Minimally Invasive Procedures (MIS) such as Ureteroscopic Lithotripsy and Laser Lithotripsy are gaining popularity due to their fewer side effects and quicker recovery time. MIS procedures include Ureteroscopic Lithotripsy, where a small scope is inserted through the urethra to reach the stone, and Laser Lithotripsy, where a laser is used to break down the stone. Cook Medical and Olympus Corporation are major players in the market for ureteroscopes. Diagnostic tools like Intravenous Pyelography, Abdominal MRI, Ultrasound, Computed Tomography, and Abdominal X-ray are used to diagnose kidney stones. Calcium Oxalate stones are the most common type, accounting for over 80% of all kidney stones. Other types include Uric Acid and Cysteine stones. Side effects of kidney stone treatments include pain, bleeding, infection, and damage to the kidney or ureter. Surgeons must weigh the risks and benefits of each treatment option for each patient. In conclusion, the Kidney Stones Therapeutic Market is expected to grow due to the increasing prevalence of urolithiasis and the development of minimally invasive procedures for treating Struvite and Calcium Oxalate stones. However, the potential side effects of these treatments must be carefully considered.
Market Research Overview
Title: Kidney Stones Therapeutic Market: A Comprehensive Overview of Urology, Laser Systems, Endoscopy, and Innovation The Kidney Stones Therapeutic Market is witnessing significant growth due to the increasing prevalence of kidney stone disease, particularly in the elderly population. Urology and otorhinolaryngology procedures play a crucial role in diagnosing and treating this condition. The market includes various product lines, from fibers and accessories for ureteroscopy and percutaneous nephrolithotomy to laser systems and imaging systems like the Dornier Delta III with OptiVision technology. Ureteroscopy and percutaneous nephrolithotomy segments are gaining popularity due to their minimally invasive nature and improved efficiencies and outcomes. Neuromodulation, rhythm management, and peripheral interventions are also emerging as potential solutions for managing kidney stones. Major players in the urology market, such as Dornier MedTech, Endoluxe, Stryker, Olympus, Cook, EDAP TMS, Medispec, Allengers, and Stryker, are investing heavily in research and development to innovate and improve stone therapy results. However, high treatment costs, lack of awareness, and side effects associated with certain treatments remain challenges. Diagnostic tools like x-ray, CT scan, intravenous pyelography, abdominal MRI, ultrasound, and abdominal x-ray are essential for accurate diagnosis. Treatment types include medications, shock wave lithotripsy, and surgical interventions like MIS procedures and open surgeries. Dietary interventions, such as limiting fast food consumption, are also crucial in managing kidney stones. The market is expected to grow further due to increased investments, contractual agreements, and the development of digital health solutions like telemedicine and diagnostic tools from companies like Sonomotion. Common types of kidney stones include calcium phosphate stones, cystine stones, and struvite kidney stones, among others. In conclusion, the Kidney Stones Therapeutic Market is a dynamic and evolving field, driven by advancements in urology, endoscopy, laser systems, and digital health solutions. The market's growth is fueled by the increasing prevalence of kidney stone disease, particularly in the elderly population, and the ongoing efforts to improve treatment outcomes and reduce side effects. However, challenges such as high treatment costs and lack of awareness remain significant barriers to access.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
